Christopher Duane Nevala-Plagemann

  • Salt Lake City, UT
  • Medical oncologist
NPI1659725851PAC ID2567728108
Medicare services, 2024
679
Medicare patients, 2024
150
Part D claims, 2024
359
Publications
16
MIPS score, 2024
90
Practice address
50 North Medical Drive, Salt Lake City, UT 84132
Practice phone
Call (801) 581-2337
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

University of Utah Hospitals and Clinics - Unit

Acute Care Hospital-Unit · Salt Lake City, Utah

See all 9 affiliations

Find Christopher Nevala-Plagemann's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Christopher Duane Nevala-Plagemann is a medical oncologist in Salt Lake City, Utah

Christopher Nevala-Plagemann practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Christopher Nevala-Plagemann's NPI, 1659725851, was assigned on April 14, 2016. Christopher Nevala-Plagemann graduated from University of Minnesota Medical School in 2016. Christopher Nevala-Plagemann holds Utah license 10514857-1205.

NPI and contact details
Medicare PAC ID
2567728108
NPI enumeration date
April 14, 2016
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(801) 581-2337
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
36
Medical school graduation
2016

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Christopher Duane Nevala-Plagemann practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah

Christopher Nevala-Plagemann's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

  • University of Utah Hospitals and Clinics - Unit
    50 North Medical Drive, Salt Lake City, UT 84132 · Salt Lake CountyPhone(801) 581-2337

Source: Dmand AI Affiliation Data

Christopher Duane Nevala-Plagemann is affiliated with 7 sites of care and 2 medical groups

Christopher Nevala-Plagemann's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Christopher Nevala-Plagemann is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Christopher Nevala-Plagemann to 3 more hospitals, 1 group practice or clinic, 1 skilled nursing facility and 1 medical group, each named with a free account.

See all 9 affiliations for Christopher Nevala-Plagemann

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Christopher Duane Nevala-Plagemann's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Nevala-Plagemann practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
University of Utah Hospitals and Clinics - UnitAvailable with a free account
+6 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Christopher Nevala-Plagemann practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Christopher Duane Nevala-Plagemann is one of 39 medical oncologists in Utah

Medical oncology is Christopher Nevala-Plagemann's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Christopher Nevala-Plagemann is licensed in Utah.

Specialties and state licenses

  • Medical oncology, UtahPrimaryLicense 10514857-1205 · taxonomy 207RX0202X

Medical oncologists near Christopher Nevala-Plagemann

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Christopher Duane Nevala-Plagemann billed Medicare for 679 services in 2024

CMS data shows 679 Medicare services from Christopher Nevala-Plagemann across 8 procedure codes in 2024, for 150 Medicare patients. Medicare paid $41,440 for them.

Medicare services, 2024679
Medicare patients150
Paid by Medicare$41,440
Procedure codes8

Christopher Nevala-Plagemann's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 3612024: 3764%
Other services
2023: 1132024: 303168%

Where Christopher Nevala-Plagemann's Medicare services took place, 2024

  • In an office49773%
  • In a facility18227%

Christopher Nevala-Plagemann compared with the Utah median for medical oncologists, 2024

  • Christopher Nevala-Plagemann
  • Utah median
Medicare services
679vs 6445% above
Medicare patients
150vs 1389% above
Part D claims
234vs 32929% below

Medians across 39 medical oncologists in Utah with Dmand AI profiles that report each measure.

Christopher Nevala-Plagemann's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Christopher Nevala-Plagemann

Need commercial claims for Christopher Nevala-Plagemann?

Medicare shows one payer. Book a meeting to get commercial claims data for Christopher Nevala-Plagemann and other medical oncologists in Utah.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Christopher Duane Nevala-Plagemann treated 150 Medicare patients in 2024, average age 73

CMS counts 150 Medicare patients who saw Christopher Nevala-Plagemann in 2024. The largest group is 65 to 74, with 79 patients. 61% of them have high blood pressure, and 59% have cancer. 11% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Nevala-Plagemann's median patient age at 71, with 45% women.

Medicare patients, 2024150
Average age73
Average risk score2.02
Also on Medicaid11%

Christopher Nevala-Plagemann's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Christopher Nevala-Plagemann's Medicare patients by sex, 2024

  • Women6845%
  • Men8255%

Chronic conditions among Christopher Nevala-Plagemann's Medicare patients, 2024

  1. High blood pressure61%
  2. Cancer59%
  3. High cholesterol44%
  4. Arthritis38%
  5. Diabetes28%
  6. Mood disorders27%
  7. Depression26%
  8. Anxiety25%

Share of Medicare patients with each condition. A patient can have several.

Christopher Nevala-Plagemann's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women45%
  • Men54%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Christopher Duane Nevala-Plagemann wrote 359 Medicare Part D claims in 2024

In 2024, Christopher Nevala-Plagemann wrote 359 Medicare Part D claims for 64 patients. 85% of them were for generic drugs. CMS names the drug for 234 of them, across 12 drugs with 11 or more claims each, at $254,545 in total drug cost. In 2023, CMS named 148 claims across 7 drugs.

Part D claims, 2024359
Drugs named by CMS12
Total drug cost$254,545
Part D patients64

Christopher Nevala-Plagemann's Part D claims by kind of drug, 2024

  • Generic305 claims85%
  • Brand-name54 claims15%

Christopher Nevala-Plagemann's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Christopher Nevala-Plagemann's Part D claims, 2024

  • Opioids7%25 of 359 claims
  • Antibiotics5%18 of 359 claims
  • Antipsychotics, patients 65 and over3%11 of 359 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1482024: 23458%

Drugs named by CMS: 12 in 2024, 7 in 2023.

See all prescribing by Christopher Nevala-Plagemann

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Christopher Duane Nevala-Plagemann scored 90 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Christopher Nevala-Plagemann for performance year 2024, reported as part of a group. Christopher Nevala-Plagemann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Nevala-Plagemann as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Christopher Nevala-Plagemann's MIPS scores, performance year 2024

  • 90of 100Final score
  • 91.5of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 74of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Christopher Nevala-Plagemann by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Christopher Duane Nevala-Plagemann has 16 publications on record

Dmand AI links 16 papers to Christopher Nevala-Plagemann, published from 2018 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Pancreatic Neoplasms and Carcinoma, Pancreatic Ductal. Christopher Nevala-Plagemann has published most often in J Natl Compr Canc Netw. Christopher Nevala-Plagemann's most frequent co-authors are Ignacio Garrido-Laguna, MD, Vaia Florou, MD and Siddharth K. Iyengar, MD.

Papers16
Years published2018 to 2025

Christopher Nevala-Plagemann's papers by year, 2018 to 2025

Topics Christopher Nevala-Plagemann writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Pancreatic Neoplasms
  • Carcinoma, Pancreatic Ductal
  • Neoplasm Metastasis
  • Adenocarcinoma
  • Colorectal Neoplasms
  • Fluorouracil
  • Leucovorin

Christopher Nevala-Plagemann's most frequent co-authors

Recent publications by Christopher Nevala-Plagemann

See all 16 publications and co-authors

See who Christopher Nevala-Plagemann researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Christopher Nevala-Plagemann works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Christopher Duane Nevala-Plagemann received $2,800 in industry payments from 2023 to 2024

CMS Open Payments shows 4 general payments to Christopher Nevala-Plagemann from 3 drug and device companies from 2023 to 2024. Consulting fees make up the largest share, 96% of the total. Seagen Inc. paid the most, $1,750.

General payments to Christopher Nevala-Plagemann by program year, 2023 to 2024

General payments to Christopher Nevala-Plagemann by kind, 2023 to 2024

$2.8Kin total
  • Consulting fees$2,67596%
  • Food and beverage$1254%

Companies that paid Christopher Nevala-Plagemann the most, 2023 to 2024

Share is of all general payments to this clinician.

See all payments to Christopher Nevala-Plagemann

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Christopher Duane Nevala-Plagemann graduated from University of Minnesota Medical School

Christopher Nevala-Plagemann graduated from University of Minnesota Medical School in 2016.

  1. Medical schoolUniversity of Minnesota Medical School

Source: Dmand AI Professional Profile Data

Sources for Christopher Duane Nevala-Plagemann's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Christopher Duane Nevala-Plagemann

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Christopher Duane Nevala-Plagemann's NPI number?

Christopher Duane Nevala-Plagemann's NPI number is 1659725851. It was assigned on April 14, 2016, and it is active in the NPI Registry.

What does Christopher Duane Nevala-Plagemann specialize in?

Christopher Duane Nevala-Plagemann is a medical oncologist in Salt Lake City, Utah. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Christopher Duane Nevala-Plagemann practice?

Christopher Nevala-Plagemann practices at 50 North Medical Drive, Salt Lake City, UT 84132. Christopher Nevala-Plagemann's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dmand AI also links Christopher Nevala-Plagemann to 3 hospitals, 1 group practice or clinic, 1 skilled nursing facility and 1 medical group.

What is Christopher Duane Nevala-Plagemann's office phone number?

The practice phone on file for Christopher Nevala-Plagemann is (801) 581-2337.

What is Christopher Duane Nevala-Plagemann's medical license number?

Christopher Nevala-Plagemann holds Utah license 10514857-1205.

Which hospitals is Christopher Duane Nevala-Plagemann affiliated with?

Christopher Nevala-Plagemann is affiliated with University of Utah Hospital. Dmand AI links Christopher Nevala-Plagemann to 4 more hospitals.

What medical group is Christopher Duane Nevala-Plagemann part of?

Christopher Nevala-Plagemann is linked to University of Utah Health. Dmand AI links Christopher Nevala-Plagemann to 1 more medical group.

Does Christopher Duane Nevala-Plagemann accept Medicare?

Yes. CMS data shows Christopher Nevala-Plagemann billed Medicare for 679 services in 2024, and Christopher Nevala-Plagemann accepts Medicare assignment.

Does Christopher Duane Nevala-Plagemann offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Christopher Nevala-Plagemann as offering telehealth services.

What is Christopher Duane Nevala-Plagemann's MIPS score?

Christopher Nevala-Plagemann's MIPS final score for performance year 2024 is 90 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Christopher Duane Nevala-Plagemann see?

CMS counts 150 Medicare patients who saw Christopher Nevala-Plagemann in 2024, with an average age of 73.

What services does Christopher Duane Nevala-Plagemann bill to Medicare?

In 2024, Christopher Nevala-Plagemann's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99215).

Where did Christopher Duane Nevala-Plagemann go to medical school?

Christopher Nevala-Plagemann graduated from University of Minnesota Medical School in 2016.

What drugs does Christopher Duane Nevala-Plagemann prescribe most?

In 2024 Medicare Part D data, Christopher Nevala-Plagemann's most prescribed drugs by claims were Ondansetron HCl, Prochlorperazine Maleate and Dexamethasone.

Has Christopher Duane Nevala-Plagemann received payments from drug or device companies?

CMS Open Payments shows $2,800 in general payments to Christopher Nevala-Plagemann from 3 companies from 2023 to 2024. The largest total came from Seagen Inc.

How long has Christopher Duane Nevala-Plagemann been practicing?

Christopher Nevala-Plagemann graduated from medical school in 2016, 10 years ago.

Does Christopher Duane Nevala-Plagemann do research?

Dmand AI links 16 publications to Christopher Nevala-Plagemann, published from 2018 to 2025.

Who does Christopher Duane Nevala-Plagemann publish with?

Christopher Nevala-Plagemann's most frequent co-authors are Ignacio Garrido-Laguna, MD (15 shared papers), Vaia Florou, MD (6 shared papers) and Siddharth K. Iyengar, MD (2 shared papers).

Selling to medical oncology practices?

See medical oncologists in Utah by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)